FDA is set to announce new warning on J&J vaccine

The U.S. Food and Drug Administration (FDA) is set to announce a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease.

Four people familiar with the situation told The Washington Post that the shot has caused instances of Guillain-Barré syndrome, a rare disorder in which the immune system attacks the peripheral nervous system, temporarily paralyzing parts of the body.

The Centers for Disease Control and Prevention (CDC) is said to have received about 100 preliminary reports of Guillain-Barré following the one-dose vaccine

We are primarily funded by readers. Please subscribe and donate to support us!

Most the cases have occurred about two weeks after vaccination and mostly in men aged 50 and older.

With just 100 cases reported out of 12.8 million doses administered, this means the condition is very rare occurring in just 0.000781 percent of cases.



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.